Eurofins DiscoverX expands program with Catalent

By The Science Advisory Board staff writers

June 29, 2020 -- Eurofins DiscoverX has expanded its contract research organization (CRO) certification program for bioassays with Catalent Biologics as the North American provider.

From its Morrisville, NC, facility in the Research Triangle Park area, Catalent can support multiple client-sponsored good laboratory practice (GLP) validation programs using the PathHunter assay platform to conduct potency lot release assays under GLP/good manufacturing practice (GMP) conditions.

The DiscoverX program was launched to support biotechnology and pharmaceutical companies and conduct potency lot release programs for bioinnovator and biosimilar drugs. The certification provides a platform to access experienced biologics analytical labs to provide potency and neutralizing antibody study support.

Now, the bioassay certification program will play a role in helping product developers prove that their drug products are safe and effective, i.e., potent. While potency can be determined using binding assays, regulators often require functional cell-based mechanism of action-reflective assays such as PathHunter.


Copyright © 2020 scienceboard.net
 


Email Address:

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.